Skip to main content
. 2021 Jun 25;22(13):6825. doi: 10.3390/ijms22136825

Table 3.

Percentages of cell in S phase after control (CTL) and gemcitabine (10 nM) for AsPC-1, BxPC-3, MIA PaCa-2 and PANC-1cell lines. * p < 0.05 (vs. control).

Cell line CTL Gemcitabine
AsPC-1 22.29 ± 2.23 28.17 ± 0.80
MIA PaCa-2 22.73 ± 1.29 32.50 ± 3.59 *
PANC-1 22.26 ± 1.69 25.03 ± 1.56
BxPC-3 21.23 ± 2.23 26.83 ± 0.77